Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$1.63 - $2.55 $30,925 - $48,381
-18,973 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$2.27 - $3.0 $174,830 - $231,054
-77,018 Reduced 80.23%
18,973 $46,000
Q3 2021

Nov 15, 2021

SELL
$2.45 - $4.1 $47,944 - $80,232
-19,569 Reduced 16.93%
95,991 $293,000
Q2 2021

Aug 16, 2021

SELL
$3.0 - $4.39 $501,168 - $733,375
-167,056 Reduced 59.11%
115,560 $450,000
Q1 2021

May 17, 2021

BUY
$2.2 - $5.05 $74,529 - $171,078
33,877 Added 13.62%
282,616 $1.01 Million
Q4 2020

Feb 16, 2021

BUY
$1.85 - $2.54 $460,167 - $631,797
248,739 New
248,739 $537,000
Q1 2020

May 15, 2020

SELL
$1.39 - $3.19 $141,055 - $323,718
-101,479 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$1.96 - $2.81 $198,898 - $285,155
101,479 New
101,479 $262,000

Others Institutions Holding SYBX

About SYNLOGIC, INC.


  • Ticker SYBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,229,600
  • Market Cap $103M
  • Description
  • Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...
More about SYBX
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.